Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial.
Roncalli J, Roubille F, Meyer N, Pompilio G, Leroux L, Henon P, Trebuchet G, Criquet A, de Kalbermatten M, Saloux E, Manrique A, Marie PY, Bhatt DL, Solomon SD, Montalescot G, Newby DE, Zannad F; EXCELLENT Trial Investigators.
Roncalli J, et al. Among authors: saloux e.
ESC Heart Fail. 2024 Dec 15. doi: 10.1002/ehf2.15124. Online ahead of print.
ESC Heart Fail. 2024.
PMID: 39676512
Free article.